Endocrine Testing Market Size, Share & Forecast to 2032

The Endocrine Testing Market is fast becoming a focal point in clinical diagnostics as health systems adapt to new technologies and demands for more efficient, data-driven patient care. Senior leaders in diagnostics, pharmaceuticals, and healthcare services must understand this market’s structural shifts to effectively steer growth and address evolving operational priorities.

Market Snapshot: Endocrine Testing Market Trends and Growth

The Endocrine Testing Market expanded from a base value of USD 10.88 billion in 2025 to USD 11.78 billion in 2026 and is projected to grow at a compound annual growth rate (CAGR) of 8.61%, reaching USD 19.42 billion by 2032. This growth reflects the sustained demand for diagnostic solutions in clinical and research environments, underscoring the market’s critical role in chronic disease management, expanding precision medicine initiatives, and supporting global population health efforts. Endocrine testing is increasingly integrated within healthcare strategies, driving improvements in both detection and ongoing patient management.

Scope & Segmentation: Comprehensive Analysis of the Endocrine Testing Market

This report offers detailed insights into every facet of the Endocrine Testing Market, equipping decision-makers with the necessary perspectives for effective planning:

Test Types: Encompasses Cortisol Tests, Dehydroepiandrosterone Sulfate (DHEAS) Tests, Estradiol (E2) Tests, Human Chorionic Gonadotropin (hCG) Hormone Tests, Insulin Tests, Sex Hormone Tests, and Thyroid Stimulating Hormone (TSH) Tests. These tests are fundamental to diagnosis and therapy adjustment across a spectrum of endocrine conditions.
Product Offerings: Includes key instrumentation such as chromatography systems, immunoassay analyzers, and mass spectrometry systems. Reagents and kits comprise calibrators, controls, and assay kits, while software and services support informatics and maintenance needs, enabling robust operational workflows.
Sample Variations: Blood, saliva, and urine are essential for providing clinicians with versatile diagnostic options and enabling patient-centric approaches, particularly in remote or resource-limited settings.
Technologies: The adoption of clinical chemistry, advanced immunoassays, monoclonal and polyclonal antibody methods, sensor technology, and tandem mass spectrometry are shaping testing accuracy and scalability.
Disease Categories: The market addresses adrenal, thyroid, diabetes, and gonadal disorders, including conditions such as Addison’s disease, Cushing’s syndrome, hypogonadism, polycystic ovary syndrome, hyperthyroidism, and hypothyroidism. Understanding these disease areas is vital for tailored diagnostic and therapeutic strategies.
End User Profiles: Major stakeholders include academic institutions, diagnostic laboratories, hospitals and clinics, and research institutes. Each group influences purchasing decisions and prioritizes compliance, quality, and innovation in solution adoption.
Regional Coverage: The Americas, EMEA (Europe, Middle East, Africa), and Asia-Pacific are included, with each region’s dynamics molded by unique regulatory landscapes, infrastructure maturity, and healthcare investment trends. These regional differences shape competitive approaches and market entry strategies.

Key Takeaways for Senior Decision-Makers

Ongoing innovation in automation, test precision, and workflow integration is transforming diagnostic accuracy and laboratory productivity for endocrine disorders.
Integrated informatics platforms and AI-driven analytics are converting laboratory data into actionable clinical guidance, supporting earlier intervention and improved outcome planning.
Point-of-care devices and sensor-based diagnostics are decentralizing the testing environment, enabling faster decision-making, from physician offices to community health programs.
Collaboration among industry, academia, and contract organizations streamlines innovation, fostering development of novel biomarkers and reducing the cycle for test introduction and regulatory approval.
Growing emphasis on sustainability is influencing procurement, with a shift toward local reagent manufacturing, energy-saving operations, and eco-conscious product development winning broader acceptance among healthcare systems.
Organizations are implementing strategic workforce development, focusing on scientific expertise, advanced analytics, and quality management to foster market leadership and adaptation to new standards.

Tariff Impact: Addressing Cost and Supply Chain Shifts

Tariff measures introduced in the United States in 2025 have reconfigured cost and sourcing frameworks for manufacturers and laboratories involved in endocrine testing. In response, organizations are increasing domestic production of essential materials, diversifying their supplier base, and renegotiating vendor agreements to stabilize costs and reduce exposure to global market volatility. Enhanced inventory strategies and closer alliances between users and equipment providers support both resilience and cost management. These shifts are driving growth in contract manufacturing and stimulating local innovation, with regulatory agencies playing a supportive role in enabling continuity and quality assurance across the endocrine diagnostics value chain.

Methodology & Data Sources

This report is built on a rigorously validated combination of primary and secondary research. In-depth interviews with executives and laboratory leaders are complemented by regulatory filings, technical literature, industry databases, and relevant case studies. Advanced data triangulation and statistical analysis ensure that the findings and recommendations reflect current industry realities and strategic opportunities.

Why This Report Matters

Delivers leaders a panoramic view of current trends, enabling proactive decisions for investment, partnership, and operational strategy in endocrine diagnostic markets worldwide.
Clarifies both clinical and technological trends, supporting organizations to adapt to new regulatory requirements and shifting healthcare priorities with confidence.
Equips stakeholders with insight into competitive and operational environments, fostering sustainable positioning and future growth within diagnostic services.

Conclusion

The Endocrine Testing Market is evolving through innovation, strategic collaborations, and responsive regulation. Senior decision-makers will benefit from timely, informed strategies to guide organizational success and leadership in diagnostic care.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Endocrine Testing Market, by Type

8.1. Cortisol Test
8.2. Dehydroepiandrosterone Sulfate (DHEAS) Test
8.3. Estradiol (E2) Test
8.4. Human Chorionic Gonadotropin (hCG) Hormone Test
8.5. Insulin Test
8.6. Sex Hormone Tests
8.7. Thyroid Stimulating Hormone (TSH) Test

9. Endocrine Testing Market, by Product Type

9.1. Instruments
9.1.1. Chromatography Systems
9.1.2. Immunoassay Analyzers
9.1.3. Mass Spectrometry Systems
9.2. Reagents & Kits
9.2.1. Calibrators
9.2.2. Control Materials
9.2.3. Diagnostic Kits
9.3. Software And Services
9.3.1. Informatics Solutions
9.3.2. Maintenance Services

10. Endocrine Testing Market, by Sample Type

10.1. Blood
10.2. Saliva
10.3. Urine

11. Endocrine Testing Market, by Technology

11.1. Clinical Chemistry
11.2. Immunoassay
11.3. Monoclonal & Polyclonal Antibody Technologies
11.4. Sensor Technology
11.5. Tandem Mass Spectrometry

12. Endocrine Testing Market, by Disease Type

12.1. Adrenal Disorders
12.1.1. Addison's Disease
12.1.2. Cushing's Syndrome
12.2. Diabetes
12.3. Gonadal Disorders
12.3.1. Hypogonadism
12.3.2. Polycystic Ovary Syndrome
12.4. Thyroid Dysfunction
12.4.1. Hyperthyroidism
12.4.2. Hypothyroidism

13. Endocrine Testing Market, by End User

13.1. Academic Institutions
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
13.4. Research Institutes

14. Endocrine Testing Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Endocrine Testing Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Endocrine Testing Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Endocrine Testing Market
18. China Endocrine Testing Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. ACON Laboratories, Inc.
19.7. Agilent Technologies, Inc.
19.8. Bio-Rad Laboratories Inc
19.9. BioCheck Inc.
19.10. Biogenix Inc. Pvt. Ltd
19.11. bioMérieux SA
19.12. Blueprint Genetics Oy
19.13. Creative Diagnostics
19.14. Danaher Corporation
19.15. Diagnostic Automation/Cortez Diagnostics Inc.
19.16. DiaSorin S.p.A.
19.17. Eagle Biosciences
19.18. EKF Diagnostics Holdings Plc
19.19. Eli Science Inc.
19.20. Eurofins Analytical Laboratories Inc.
19.21. F. Hoffmann-La Roche Ltd
19.22. Getein Biotech, Inc.
19.23. Laboratory Corporation of America Holdings
19.24. MP Biomedicals, LLC
19.25. Ortho-Clinical Diagnostics, Inc.
19.26. Quest Diagnostics Incorporated
19.27. Randox Laboratories Ltd.
19.28. Shenzhen New Industries Biomedical Engineering Co., Ltd.
19.29. Siemens Healthcare GmbH
19.30. Thermo Fisher Scientific Inc.
19.31. Trivitron Healthcare

List of Figures

FIGURE 1. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. EUROPE ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 194. EUROPE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. EUROPE ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPE ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 199. EUROPE ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 215. AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 217. AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 218. AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 219. AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 220. AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 222. AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 223. AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 224. AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 225. AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. ASEAN ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. ASEAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 242. ASEAN ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. ASEAN ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 244. ASEAN ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 245. ASEAN ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 246. ASEAN ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 247. ASEAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. ASEAN ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 249. ASEAN ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 250. ASEAN ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 251. ASEAN ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 252. ASEAN ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. GCC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. GCC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 255. GCC ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. GCC ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 257. GCC ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 258. GCC ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 259. GCC ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 260. GCC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. GCC ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 262. GCC ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 263. GCC ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 264. GCC ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 265. GCC ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. BRICS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. BRICS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 281. BRICS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 282. BRICS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 283. BRICS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 284. BRICS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 285. BRICS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 286. BRICS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. BRICS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 288. BRICS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 289. BRICS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 290. BRICS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 291. BRICS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. G7 ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 293. G7 ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 294. G7 ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 295. G7 ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 296. G7 ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 297. G7 ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 298. G7 ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 299. G7 ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 300. G7 ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 301. G7 ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 302. G7 ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 303. G7 ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 304. G7 ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. NATO ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 306. NATO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 307. NATO ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 308. NATO ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 309. NATO ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 310. NATO ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 311. NATO ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 312. NATO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 313. NATO ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 314. NATO ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 315. NATO ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 316. NATO ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 317. NATO ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 318. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 321. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 323. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 324. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 325. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 326. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 327. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 330. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 332. CHINA ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2

Companies Mentioned

The key companies profiled in this Endocrine Testing market report include:

Abbott Laboratories
ACON Laboratories, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories Inc
BioCheck Inc.
Biogenix Inc. Pvt. Ltd
bioMérieux SA
Blueprint Genetics Oy
Creative Diagnostics
Danaher Corporation
Diagnostic Automation/Cortez Diagnostics Inc.
DiaSorin S.p.A.
Eagle Biosciences
EKF Diagnostics Holdings Plc
Eli Science Inc.
Eurofins Analytical Laboratories Inc.
F. Hoffmann-La Roche Ltd
Getein Biotech, Inc.
Laboratory Corporation of America Holdings
MP Biomedicals, LLC
Ortho-Clinical Diagnostics, Inc.
Quest Diagnostics Incorporated
Randox Laboratories Ltd.
Shenzhen New Industries Biomedical Engineering Co., Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Trivitron Healthcare

Table Information

Report Attribute	Details
No. of Pages	181
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 11.78 Billion
Forecasted Market Value ( USD ) by 2032	$ 19.42 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	28

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3450EUR$3,939USD£2,994GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3721EUR$4,249USD£3,230GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5044EUR$5,759USD£4,378GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6104EUR$6,969USD£5,298GBP

Endocrine Testing Market - Global Forecast 2026-2032

Market Snapshot: Endocrine Testing Market Trends and Growth

Scope & Segmentation: Comprehensive Analysis of the Endocrine Testing Market

Key Takeaways for Senior Decision-Makers